An Engineered Allogeneic Artificial Antigen-Presenting Red Cell Therapeutic, RTX-321, for HPV16+ Associated Cancers Promotes Antigen-Specific T Cell Activation and Expansion
Shamael R. Dastagir, Xuqing Zhang, Albert Lee, Timothy J. Lyford, Jennifer M. Mellen, Andrea Schmidt, Mary Gribble, Chris Moore, Thomas J. Wickham, and Tiffany F. Chen